BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29246678)

  • 1. Individualized Fracture Risk Feedback and Long-term Benefits After 10 Years.
    Wu F; Wills K; Laslett LL; Riley MD; Oldenburg B; Jones G; Winzenberg T
    Am J Prev Med; 2018 Feb; 54(2):266-274. PubMed ID: 29246678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect on behavior and bone mineral density of individualized bone mineral density feedback and educational interventions in premenopausal women: a randomized controlled trial [NCT00273260].
    Winzenberg T; Oldenburg B; Frendin S; De Wit L; Riley M; Jones G
    BMC Public Health; 2006 Jan; 6():12. PubMed ID: 16430773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone density testing: an under-utilised and under-researched health education tool for osteoporosis prevention?
    Winzenberg T; Oldenburg B; Jones G
    Nutrients; 2010 Sep; 2(9):985-96. PubMed ID: 22254067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of individualized bone density feedback and educational interventions on osteoporosis knowledge and self-efficacy: a 12-yr prospective study.
    Wu F; Laslett LL; Wills K; Oldenburg B; Jones G; Winzenberg T
    J Clin Densitom; 2014; 17(4):466-72. PubMed ID: 25220886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
    Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
    Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS).
    Kemmler W; Bebenek M; Kohl M; von Stengel S
    Osteoporos Int; 2015 Oct; 26(10):2491-9. PubMed ID: 25963237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial.
    Cheung AM; Tile L; Cardew S; Pruthi S; Robbins J; Tomlinson G; Kapral MK; Khosla S; Majumdar S; Erlandson M; Scher J; Hu H; Demaras A; Lickley L; Bordeleau L; Elser C; Ingle J; Richardson H; Goss PE
    Lancet Oncol; 2012 Mar; 13(3):275-84. PubMed ID: 22318095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.
    Bernstein CN; Bector S; Leslie WD
    Am J Gastroenterol; 2003 Nov; 98(11):2468-73. PubMed ID: 14638350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study.
    Jamal SA; Ridout R; Chase C; Fielding L; Rubin LA; Hawker GA
    J Bone Miner Res; 1999 Dec; 14(12):2143-9. PubMed ID: 10620074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women.
    Marci CD; Anderson WB; Viechnicki MB; Greenspan SL
    Calcif Tissue Int; 2000 Feb; 66(2):113-8. PubMed ID: 10652958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.
    Frediani B; Falsetti P; Baldi F; Acciai C; Filippou G; Marcolongo R
    Bone; 2003 Oct; 33(4):575-81. PubMed ID: 14555261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing fracture risk with calcium and vitamin D.
    Lips P; Bouillon R; van Schoor NM; Vanderschueren D; Verschueren S; Kuchuk N; Milisen K; Boonen S
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):277-85. PubMed ID: 20796001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?
    Bolland MJ; Grey A; Reid IR
    Climacteric; 2015; 18 Suppl 2():22-31. PubMed ID: 26473773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The LIFTMOR-M (Lifting Intervention For Training Muscle and Osteoporosis Rehabilitation for Men) trial: protocol for a semirandomised controlled trial of supervised targeted exercise to reduce risk of osteoporotic fracture in older men with low bone mass.
    Harding AT; Weeks BK; Watson SL; Beck BR
    BMJ Open; 2017 Jun; 7(6):e014951. PubMed ID: 28611110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of osteoporosis risk and initiation of a nurse practitioner intervention program in an orthopedic practice.
    Seuffert P; Sagebien CA; McDonnell M; O'Hara DA
    Arch Osteoporos; 2016; 11():10. PubMed ID: 26847628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis.
    Beck BR; Daly RM; Singh MA; Taaffe DR
    J Sci Med Sport; 2017 May; 20(5):438-445. PubMed ID: 27840033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis.
    Reid IR; Bolland MJ; Grey A
    Lancet; 2014 Jan; 383(9912):146-55. PubMed ID: 24119980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year denosumab treatment in postmenopausal Japanese women and men with osteoporosis: results from a 1-year open-label extension of the Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT).
    Sugimoto T; Matsumoto T; Hosoi T; Miki T; Gorai I; Yoshikawa H; Tanaka Y; Tanaka S; Fukunaga M; Sone T; Nakano T; Ito M; Matsui S; Yoneda T; Takami H; Watanabe K; Osakabe T; Okubo N; Shiraki M; Nakamura T
    Osteoporos Int; 2015 Feb; 26(2):765-74. PubMed ID: 25403903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.